- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
From
WORLD
Feb 8, 2013
DNA testers latch on to scandal
Full tests cost £300 and can check for only one species
From
HEALTH CARE
Feb 7, 2013
S&N solid finish outweighs weaker outlook
Good news on knee implants and wound management buoy Smith & Nephew
- Lombard Burberry / Tax rates / Smith& Nephew
- Andrew Hill Strategy lessons, 101
Feb 6, 2013
Biogen to buy Elan’s stake in MS drug
US biotechnology company to pay $3.25bn in cash for full control of Tysabri
©Getty
Feb 6, 2013
GSK unveils European restructuring plans
Lucozade and Ribena drinks brands placed under review
From
LEX
Feb 6, 2013
Elan / Biogen: where are the drugs?
Biotech group needs a new strategy now more than ever
From
TECHNOLOGY
Feb 4, 2013
Needle-free syringe passes test on mice
Technique could improve distribution of fragile vaccines
From
MANAGEMENT
Feb 4, 2013
A new corporate focus
When Japanese pharma company Takeda tried to become more global, changing its internal culture started at the top
John Authers
from
FINANCIALS
Feb 3, 2013
Activist spat distracts from real targets
All the signs suggest this is a great time to take aim at boards
Jan 31, 2013
AstraZeneca warns of tough year ahead
Focus at Anglo-Swedish drugmaker is on organic growth
From
LEX
Jan 31, 2013
AstraZeneca: don’t look now
Anglo-Swedish drugmaker’s results reflect how tough restoration will be
Jan 30, 2013
Roche boosted by robust US sales
Swiss pharma group expects European market to remain weak
Jan 28, 2013
Sanofi launches talking injection device
Device for people suffering from extreme allergic reactions
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
-
Ombudsmen
Financial Ombudsman Service
-
Divisional Director
EMIS
-
Head of Treasury - Manchester
Manchester Airport Group
-
CHIEF EXECUTIVE
Building Societies Association
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Novo Nordisk: reality check
The specialist in diabetic treatments gets hit by an FDA ruling